APP
LLY icon

Alpha Paradigm Partners’s Eli Lilly LLY Stock Holding History

Alpha Paradigm Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$81K Buy
221
+128
+138% +$45.4K 0.03% 393
2022
Q3 		$30K Sell
93
-1,372
-94% -$435K 0.01% 424
2022
Q2 		$475K Buy
+1,465
New +$440K 0.2% 190

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alpha Paradigm Partners's LLY Position: Q4 2022 in Review

Alpha Paradigm Partners increased its Eli Lilly (LLY) stake by 138% in Q4 2022, buying an estimated $45.4K and bringing the position to 221 shares worth $81K. The position accounts for 0.03% of the portfolio, ranked #393.

Alpha Paradigm Partners first reported a position in LLY in Q2 2022 and has held it in 3 quarters since. The position peaked at $475K in Q2 2022. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Alpha Paradigm Partners held 221 shares of Eli Lilly worth $81K as of Q4 2022.
  • Alpha Paradigm Partners bought 128 Eli Lilly shares in Q4 2022, an estimated $45.4K.
  • Eli Lilly made up 0.03% of Alpha Paradigm Partners's portfolio in Q4 2022, its #393 holding.
  • Alpha Paradigm Partners first reported a position in Eli Lilly in Q2 2022 and has held it in 3 quarters since.
  • Alpha Paradigm Partners's Eli Lilly position peaked at $475K in Q2 2022.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.